This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Varughese, M.
Right arrow Articles by Leppla, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Varughese, M.
Right arrow Articles by Leppla, S. H.

 Previous Article  |  Next Article 

Infection and Immunity, April 1999, p. 1860-1865, Vol. 67, No. 4
0019-9567/99/$04.00+0

Identification of a Receptor-Binding Region within Domain 4 of the Protective Antigen Component of Anthrax Toxin

Mini Varughese, Avelino V. Teixeira,dagger Shihui Liu, and Stephen H. Leppla*

Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892

Received 10 November 1998/Returned for modification 9 December 1998/Accepted 14 January 1999

Anthrax toxin from Bacillus anthracis is a three-component toxin consisting of lethal factor (LF), edema factor (EF), and protective antigen (PA). LF and EF are the catalytic components of the toxin, whereas PA is the receptor-binding component. To identify residues of PA that are involved in interaction with the cellular receptor, two solvent-exposed loops of domain 4 of PA (amino acids [aa] 679 to 693 and 704 to 723) were mutagenized, and the altered proteins purified and tested for toxicity in the presence of LF. In addition to the intended substitutions, novel mutations were introduced by errors that occurred during PCR. Substitutions within the large loop (aa 704 to 723) had no effect on PA activity. A mutated protein, LST-35, with three substitutions in the small loop (aa 679 to 693), bound weakly to the receptor and was nontoxic. A mutated protein, LST-8, with changes in three separate regions did not bind to receptor and was nontoxic. Toxicity was greatly decreased by truncation of the C-terminal 3 to 5 aa, but not by their substitution with nonnative residues or the extension of the terminus with nonnative sequences. Comparison of the 28 mutant proteins described here showed that the large loop (aa 704 to 722) is not involved in receptor binding, whereas residues in and near the small loop (aa 679 to 693) play an important role in receptor interaction. Other regions of domain 4, in particular residues at the extreme C terminus, appear to play a role in stabilizing a conformation needed for receptor-binding activity.

* Corresponding author. Mailing address: Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, Bldg. 30, Room 316, 30 Convent Dr. MSC 4350, Bethesda, MD 20892-4350. Phone: (301) 594-2865. Fax: (301) 402-0396. E-mail: leppla{at}nih.gov.

dagger Present address: Division of Nephrology, Mount Sinai School of Medicine, New York, NY 10029-6574.

Infection and Immunity, April 1999, p. 1860-1865, Vol. 67, No. 4
0019-9567/99/$04.00+0


This article has been cited by other articles:

  • Kelly-Cirino, C. D., Mantis, N. J. (2009). Neutralizing Monoclonal Antibodies Directed against Defined Linear Epitopes on Domain 4 of Anthrax Protective Antigen. Infect. Immun. 77: 4859-4867 [Abstract] [Full Text]  
  • Liu, S., Crown, D., Miller-Randolph, S., Moayeri, M., Wang, H., Hu, H., Morley, T., Leppla, S. H. (2009). Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo. Proc. Natl. Acad. Sci. USA 106: 12424-12429 [Abstract] [Full Text]  
  • Tang, S., Moayeri, M., Chen, Z., Harma, H., Zhao, J., Hu, H., Purcell, R. H., Leppla, S. H., Hewlett, I. K. (2009). Detection of Anthrax Toxin by an Ultrasensitive Immunoassay Using Europium Nanoparticles. CVI 16: 408-413 [Abstract] [Full Text]  
  • Abboud, N., Casadevall, A. (2008). Immunogenicity of Bacillus anthracis Protective Antigen Domains and Efficacy of Elicited Antibody Responses Depend on Host Genetic Background. CVI 15: 1115-1123 [Abstract] [Full Text]  
  • Albrecht, M. T., Li, H., Williamson, E. D., LeButt, C. S., Flick-Smith, H. C., Quinn, C. P., Westra, H., Galloway, D., Mateczun, A., Goldman, S., Groen, H., Baillie, L. W. J. (2007). Human Monoclonal Antibodies against Anthrax Lethal Factor and Protective Antigen Act Independently To Protect against Bacillus anthracis Infection and Enhance Endogenous Immunity to Anthrax. Infect. Immun. 75: 5425-5433 [Abstract] [Full Text]  
  • Peterson, J. W., Comer, J. E., Baze, W. B., Noffsinger, D. M., Wenglikowski, A., Walberg, K. G., Hardcastle, J., Pawlik, J., Bush, K., Taormina, J., Moen, S., Thomas, J., Chatuev, B. M., Sower, L., Chopra, A. K., Stanberry, L. R., Sawada, R., Scholz, W. W., Sircar, J. (2007). Human Monoclonal Antibody AVP-21D9 to Protective Antigen Reduces Dissemination of the Bacillus anthracis Ames Strain from the Lungs in a Rabbit Model. Infect. Immun. 75: 3414-3424 [Abstract] [Full Text]  
  • Chen, K.-H., Liu, S., Bankston, L. A., Liddington, R. C., Leppla, S. H. (2007). Selection of Anthrax Toxin Protective Antigen Variants That Discriminate between the Cellular Receptors TEM8 and CMG2 and Achieve Targeting of Tumor Cells. J. Biol. Chem. 282: 9834-9845 [Abstract] [Full Text]  
  • Zomber, G., Reuveny, S., Garti, N., Shafferman, A., Elhanany, E. (2005). Effects of Spontaneous Deamidation on the Cytotoxic Activity of the Bacillus anthracis Protective Antigen. J. Biol. Chem. 280: 39897-39906 [Abstract] [Full Text]  
  • Williamson, E. D., Hodgson, I., Walker, N. J., Topping, A. W., Duchars, M. G., Mott, J. M., Estep, J., LeButt, C., Flick-Smith, H. C., Jones, H. E., Li, H., Quinn, C. P. (2005). Immunogenicity of Recombinant Protective Antigen and Efficacy against Aerosol Challenge with Anthrax. Infect. Immun. 73: 5978-5987 [Abstract] [Full Text]  
  • Laffly, E., Danjou, L., Condemine, F., Vidal, D., Drouet, E., Lefranc, M.-P., Bottex, C., Thullier, P. (2005). Selection of a Macaque Fab with Framework Regions Like Those in Humans, High Affinity, and Ability To Neutralize the Protective Antigen (PA) of Bacillus anthracis by Binding to the Segment of PA between Residues 686 and 694. Antimicrob. Agents Chemother. 49: 3414-3420 [Abstract] [Full Text]  
  • Opal, S. M., Artenstein, A. W., Cristofaro, P. A., Jhung, J. W., Palardy, J. E., Parejo, N. A., Lim, Y.-P. (2005). Inter-Alpha-Inhibitor Proteins Are Endogenous Furin Inhibitors and Provide Protection against Experimental Anthrax Intoxication. Infect. Immun. 73: 5101-5105 [Abstract] [Full Text]  
  • Galen, J. E., Zhao, L., Chinchilla, M., Wang, J. Y., Pasetti, M. F., Green, J., Levine, M. M. (2004). Adaptation of the Endogenous Salmonella enterica Serovar Typhi clyA-Encoded Hemolysin for Antigen Export Enhances the Immunogenicity of Anthrax Protective Antigen Domain 4 Expressed by the Attenuated Live-Vector Vaccine Strain CVD 908-htrA. Infect. Immun. 72: 7096-7106 [Abstract] [Full Text]  
  • Brossier, F., Levy, M., Landier, A., Lafaye, P., Mock, M. (2004). Functional Analysis of Bacillus anthracis Protective Antigen by Using Neutralizing Monoclonal Antibodies. Infect. Immun. 72: 6313-6317 [Abstract] [Full Text]  
  • Lacy, D. B., Wigelsworth, D. J., Melnyk, R. A., Harrison, S. C., Collier, R. J. (2004). Structure of heptameric protective antigen bound to an anthrax toxin receptor: A role for receptor in pH-dependent pore formation. Proc. Natl. Acad. Sci. USA 101: 13147-13151 [Abstract] [Full Text]  
  • Barth, H., Aktories, K., Popoff, M. R., Stiles, B. G. (2004). Binary Bacterial Toxins: Biochemistry, Biology, and Applications of Common Clostridium and Bacillus Proteins. Microbiol. Mol. Biol. Rev. 68: 373-402 [Abstract] [Full Text]  
  • Bradley, K. A., Mogridge, J., Jonah, G., Rainey, A., Batty, S., Young, J. A. T. (2003). Binding of Anthrax Toxin to Its Receptor Is Similar to {alpha} Integrin-Ligand Interactions. J. Biol. Chem. 278: 49342-49347 [Abstract] [Full Text]  
  • Mourez, M., Yan, M., Lacy, D. B., Dillon, L., Bentsen, L., Marpoe, A., Maurin, C., Hotze, E., Wigelsworth, D., Pimental, R.-A., Ballard, J. D., Collier, R. J., Tweten, R. K. (2003). Mapping dominant-negative mutations of anthrax protective antigen by scanning mutagenesis. Proc. Natl. Acad. Sci. USA 100: 13803-13808 [Abstract] [Full Text]  
  • Rosovitz, M. J., Schuck, P., Varughese, M., Chopra, A. P., Mehra, V., Singh, Y., McGinnis, L. M., Leppla, S. H. (2003). Alanine-scanning Mutations in Domain 4 of Anthrax Toxin Protective Antigen Reveal Residues Important for Binding to the Cellular Receptor and to a Neutralizing Monoclonal Antibody. J. Biol. Chem. 278: 30936-30944 [Abstract] [Full Text]  
  • Flick-Smith, H. C., Walker, N. J., Gibson, P., Bullifent, H., Hayward, S., Miller, J., Titball, R. W., Williamson, E. D. (2002). A Recombinant Carboxy-Terminal Domain of the Protective Antigen of Bacillus anthracis Protects Mice against Anthrax Infection. Infect. Immun. 70: 1653-1656 [Abstract] [Full Text]  
  • Marvaud, J.-C., Smith, T., Hale, M. L., Popoff, M. R., Smith, L. A., Stiles, B. G. (2001). Clostridium perfringens Iota-Toxin: Mapping of Receptor Binding and Ia Docking Domains on Ib. Infect. Immun. 69: 2435-2441 [Abstract] [Full Text]  
  • Liu, S., Netzel-Arnett, S., Birkedal-Hansen, H., Leppla, S. H. (2000). Tumor Cell-selective Cytotoxicity of Matrix Metalloproteinase-activated Anthrax Toxin. Cancer Res. 60: 6061-6067 [Abstract] [Full Text]  
  • Blocker, D., Barth, H., Maier, E., Benz, R., Barbieri, J. T., Aktories, K. (2000). The C Terminus of Component C2II of Clostridium botulinum C2 Toxin Is Essential for Receptor Binding. Infect. Immun. 68: 4566-4573 [Abstract] [Full Text]  
  • Brossier, F., Weber-Levy, M., Mock, M., Sirard, J.-C. (2000). Role of Toxin Functional Domains in Anthrax Pathogenesis. Infect. Immun. 68: 1781-1786 [Abstract] [Full Text]  
  • Liu, S., Bugge, T. H., Leppla, S. H. (2001). Targeting of Tumor Cells by Cell Surface Urokinase Plasminogen Activator-dependent Anthrax Toxin. J. Biol. Chem. 276: 17976-17984 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»